Phenylketonuria (PKU) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL PHENYLKETONURIA (PKU) INDUSTRY

2.1 Summary about Phenylketonuria (PKU) Industry

2.2 Phenylketonuria (PKU) Market Trends

2.2.1 Phenylketonuria (PKU) Production & Consumption Trends

2.2.2 Phenylketonuria (PKU) Demand Structure Trends

2.3 Phenylketonuria (PKU) Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Medications

4.2.2 Supplements

4.2.3 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Household

4.3.2 Hospital

4.3.3 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Medications

5.2.2 Supplements

5.2.3 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Household

5.3.2 Hospital

5.3.3 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Medications

6.2.2 Supplements

6.2.3 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Household

6.3.2 Hospital

6.3.3 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Medications

7.2.2 Supplements

7.2.3 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Household

7.3.2 Hospital

7.3.3 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Medications

8.2.2 Supplements

8.2.3 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Household

8.3.2 Hospital

8.3.3 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Medications

9.2.2 Supplements

9.2.3 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Household

9.3.2 Hospital

9.3.3 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Biomarin

10.1.2 Vitaflo

10.1.3 Mead Johnson

10.1.4 Nutricia

10.1.5 Cambrooke

10.1.6 Dr. Schär

10.1.7 Prominmetabolics

10.1.8 PKU Perspectives

10.2 Phenylketonuria (PKU) Sales Date of Major Players (2017-2020e)

10.2.1 Biomarin

10.2.2 Vitaflo

10.2.3 Mead Johnson

10.2.4 Nutricia

10.2.5 Cambrooke

10.2.6 Dr. Schär

10.2.7 Prominmetabolics

10.2.8 PKU Perspectives

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Phenylketonuria (PKU) Product Type Overview

2.Table Phenylketonuria (PKU) Product Type Market Share List

3.Table Phenylketonuria (PKU) Product Type of Major Players

4.Table Brief Introduction of Biomarin

5.Table Brief Introduction of Vitaflo

6.Table Brief Introduction of Mead Johnson

7.Table Brief Introduction of Nutricia

8.Table Brief Introduction of Cambrooke

9.Table Brief Introduction of Dr. Schär

10.Table Brief Introduction of Prominmetabolics

11.Table Brief Introduction of PKU Perspectives

12.Table Products & Services of Biomarin

13.Table Products & Services of Vitaflo

14.Table Products & Services of Mead Johnson

15.Table Products & Services of Nutricia

16.Table Products & Services of Cambrooke

17.Table Products & Services of Dr. Schär

18.Table Products & Services of Prominmetabolics

19.Table Products & Services of PKU Perspectives

20.Table Market Distribution of Major Players

21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

23.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) by Region 2021f-2026f

24.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) Share by Region 2021f-2026f

25.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) by Demand 2021f-2026f

26.Table Global Phenylketonuria (PKU) Market Forecast (Million USD) Share by Demand 2021f-2026f